Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease.
about
Role of cytokines and chemokines in non-alcoholic fatty liver diseaseAdvances in cholangiocyte immunobiologyProliferating bile duct epithelial cells are a major source of connective tissue growth factor in rat biliary fibrosisExpression and location of Smad2, 4 mRNAs during and after liver fibrogenesis of ratsActivation of the MEK5/ERK5 cascade is responsible for biliary dysgenesis in a rat model of Caroli's diseaseNAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.Mechanisms of fibrogenesis in liver cirrhosis: The molecular aspects of epithelial-mesenchymal transitionMacrophage-mediated phagocytosis of apoptotic cholangiocytes contributes to reversal of experimental biliary fibrosis.Anchoring hepatic gene expression with development of fibrosis and neoplasia in a toxicant-induced fish model of liver injuryImmunohistochemical study for the origin of ductular reaction in chronic liver disease.Toxicogenomic analysis reveals profibrogenic effects of trichloroethylene in autoimmune-mediated cholangitis in miceImmunomodulatory effects of transforming growth factor-β in the liver.Involvement of cholangiocyte proliferation in biliary fibrosis.Wound healing in the liver with particular reference to stem cellsIdentification of novel molecules and pathogenic pathways in primary biliary cirrhosis: cDNA array analysis of intrahepatic differential gene expression.Prevention of critical telomere shortening by oestradiol in human normal hepatic cultured cells and carbon tetrachloride induced rat liver fibrosisHepatic artery and portal vein remodeling in rat liver: vascular response to selective cholangiocyte proliferation.Cell-specific expression of transforming growth factor-beta in rat liver. Evidence for autocrine regulation of hepatocyte proliferation.Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.Transforming growth factors-beta 1, -beta 2, and -beta 3 stimulate fibroblast procollagen production in vitro but are differentially expressed during bleomycin-induced lung fibrosisTissue inhibitor of metalloproteinase-1 and -2 RNA expression in rat and human liver fibrosisCell-type-specific expression of neural cell adhesion molecule (N-CAM) in Ito cells of rat liver. Up-regulation during in vitro activation and in hepatic tissue repair.Transforming growth factor-beta initiates wound repair in rat liver through induction of the EIIIA-fibronectin splice isoform.Expression of transforming growth factor-beta 1 and its relation to endomysial fibrosis in progressive muscular dystrophy.Sequential expression of cellular fibronectin by platelets, macrophages, and mesangial cells in proliferative glomerulonephritis.Hsp90 and hepatobiliary transformation during sea lamprey metamorphosis.Notch signaling affects biliary fibrosis via transcriptional regulation of RBP-jκ in an animal model of chronic liver disease.The Genetic Basis of Peyronie's Disease: A Review.Fibrin deposition following bile duct injury limits fibrosis through an αMβ2-dependent mechanismBiliary epithelial senescence and plasticity in acute cellular rejectionCholangiocyte proliferation and liver fibrosis.Autocrine regulation of biliary pathology by activated cholangiocytes.TGF-β1 and TGF-β2 abundance in liver diseases of mice and menHistological features predictive of liver fibrosis in chronic hepatitis C infectionSophocarpine attenuates liver fibrosis by inhibiting the TLR4 signaling pathway in rats.Portal fibroblasts: Underappreciated mediators of biliary fibrosis.Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases.Epithelial-mesenchymal interactions in biliary diseasesHuman liver myofibroblasts during development and diseases with a focus on portal (myo)fibroblasts.Epithelial-mesenchymal transition in liver fibrosis
P2860
Q26830328-42FE5722-2724-4921-8490-4649ADF9715EQ27002954-EABB2268-6EBE-4172-BAEF-A3CD69D2A17EQ28362052-7EFD5F1B-0206-4E39-9A8D-40146C16BCEBQ28564457-90987EBB-4D65-47B2-83EB-57EEC5DB3277Q28578050-F185FDEA-6473-4040-A586-86D0F22BC82BQ33562191-9652CDFA-2270-4D8B-BBA1-1F7CD9E91188Q33563882-BBF9FEE1-27C9-4F86-A763-FAD953E441A1Q33727374-DF2CD6D7-27F1-4F45-A475-F8E7B29709BCQ33894802-C6F96ED9-4DF4-4895-8B7C-303B98DBDAB1Q34029126-FB9C5235-08AF-4019-A960-23CD5F4113E6Q34736314-073FAD85-4A38-4E82-BB10-64D4BAC5CB09Q34750481-FE2ADDCF-D806-44E0-969E-99C6436767F7Q34992326-830324B9-26E5-4339-ACC6-F4D8468CF98FQ35212061-8639E7F1-8B47-4F4D-A0D0-19D9E9AE9CFEQ35365390-00882D1D-3C58-4F0F-ADA4-9E2013170353Q35596619-B03F9145-9798-47B0-A821-D18BEAD8CE58Q35749261-A6855B29-9807-4484-A916-1CA743F58265Q35750826-7A42E577-9760-4389-9291-634D46D65F46Q35753253-2BCA04EC-BC80-4FB6-9BF4-CB46513EF4CBQ35763549-C32ADF7C-6918-4B9C-BB59-6AB1CE8BB26AQ35764453-C84E5BC5-8766-4758-8C69-4D0936CD3550Q35782617-F43B2668-2F35-4D64-83E2-4BF6295C5CA5Q35793352-40F535A0-7E4D-46A0-AF46-92CF5C4E13D7Q35833406-53E1997C-B53B-41E7-9F6A-AD7D08CBF179Q35839302-CAAAD618-7437-4048-A941-9E0F87631CE7Q35857968-DCC60046-320A-4B3E-8304-0A68C3A690F9Q36375200-B51757DE-54BB-4054-899F-84B4D3A0DEC3Q36651563-3F26209A-44E4-489E-A51E-841CCAACCFEBQ36965875-1AE23878-922E-4A43-9104-FCB979C2AE79Q37101672-4A4D5F37-DC40-48C7-BABF-FB54C514BC37Q37175438-B3C4073F-950D-421F-99E8-8AAFC70EBC6EQ37175512-6208A059-EF01-43EF-B11E-762A3C04314AQ37190089-11F818C5-FD4B-4984-977A-6BA145435BC2Q37200957-B3D1D2F3-6142-466C-974B-CCB0EC9A7332Q37596197-9FAB89E9-C3C7-4A44-A19F-8827374C8F56Q37704267-3A3871C4-9F9C-4475-909D-30F0FEE56BA4Q37838705-DB412BB8-A90E-4619-82E1-75CE40726A44Q37846143-57B3817F-1C5B-45B2-A50D-793C485332ABQ38544274-73E0C016-31FA-46C5-8355-5BD6DC48D66AQ38718014-FABE65DC-9FB7-4F08-9A0B-3AFE9226E374
P2860
Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Transforming growth factors be ...... sed in fibrotic liver disease.
@ast
Transforming growth factors be ...... sed in fibrotic liver disease.
@en
type
label
Transforming growth factors be ...... sed in fibrotic liver disease.
@ast
Transforming growth factors be ...... sed in fibrotic liver disease.
@en
prefLabel
Transforming growth factors be ...... sed in fibrotic liver disease.
@ast
Transforming growth factors be ...... sed in fibrotic liver disease.
@en
P2093
P2860
P1476
Transforming growth factors be ...... sed in fibrotic liver disease.
@en
P2093
P2860
P304
P407
P577
1991-12-01T00:00:00Z